RIV4: Clinical Trials

5 trials of RIV4, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown. 2 Phase 2, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1
Phase 11Completed 1
Phase 41Unknown 1

Follow RIV4: new trials by email Literature Review of RIV4 trials Research Report on RIV4

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older
Influenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant Influenza Vaccine - Influenza, Influenza Immunization
Phase 1CompletedSanofi Pasteur, a Sanofi Company3882022-04-112023-11-07
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults
Investigational aIIV4c, IIV4c, aIIV4 - Influenza, Human
Phase 2CompletedSeqirus4712020-10-082024-04-17
Recombinant Influenza Vaccination in U.S. Nursing Homes
Recombinant Influenza Vaccine, Standard Dose Quadrivalent Influenza Vaccine - Influenza, Influenza -Like Illness
Phase 4UnknownInsight Therapeutics, LLC19892019-07-202023-03-15
Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their Offspring
Flublok Quadrivalent influenza vaccine RIV4, Standard-dose quadrivalent inactivated influenza vaccine SD-IIV4 - Influenza
CompletedSanofi Pasteur, a Sanofi Company961752018-09-172022-05-24
Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years
VAX2012Q, Fluzone Quadrivalent - Influenza
Phase 2UnknownVaxInnate Corporation4502015-05-012015-06-26

Conditions studied

Influenza, Human (5)

Sponsors

Sanofi Pasteur, a Sanofi Company (2)  ·  Insight Therapeutics, LLC (1)  ·  Seqirus (1)  ·  VaxInnate Corporation (1)

Countries

United States (5)

Top investigators

H. Edward Davidson, PharmD, MPH (1)  ·  Stefan Gravenstein, MD, MPH (1)  ·  Stephen J. Haworth, MD (1)

Results publications

PMID 39745702, PMID 39946829